Price

rebased to 0%

INMB, solidAMGN, dashed

INMBInmune Bio, Inc.

1.19· pre 1.26· delayed

Mkt cap$35.5MRevenue$50,000Q1 FY25Revenue—

AMGNAmgen Inc

461.49· pre 452.20· delayed

Pre-marketNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

Pre-marketNov 6 '26delayed

INMBInmune Bio, Inc.

vs

AMGNAmgen Inc

1.19pre 1.26delayed

Price

461.49pre 452.20delayed

$35.5M

Mkt cap

$249.0B

Q1 FY25$50,000

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

INMB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name